American International Group, Inc. X Biotech Inc. Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.13 - $9.2 $38,787 - $69,561	-7,561 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.64 - $11.71 $4,596 - $6,229	-532 Reduced 6.57%	7,561 $65,000
Q4 2021 Feb 11, 2022	SELL	$10.95 - $16.07 $2,649 - $3,888	-242 Reduced 2.9%	8,093 $90,000
Q3 2021 Nov 12, 2021	SELL	$12.95 - $18.24 $1,126 - $1,586	-87 Reduced 1.03%	8,335 $108,000
Q2 2021 Aug 13, 2021	SELL	$15.83 - $17.84 $205 - $231	-13 Reduced 0.15%	8,422 $139,000
Q1 2021 May 07, 2021	BUY	$15.92 - $20.3 $350 - $446	22 Added 0.26%	8,435 $145,000
Q4 2020 Feb 12, 2021	SELL	$15.65 - $19.92 $1,893 - $2,410	-121 Reduced 1.42%	8,413 $132,000
Q3 2020 Nov 04, 2020	SELL	$13.97 - $21.16 $2,696 - $4,083	-193 Reduced 2.21%	8,534 $163,000
Q2 2020 Aug 12, 2020	BUY	$10.39 - $16.07 $9,953 - $15,395	958 Added 12.33%	8,727 $120,000
Q1 2020 May 04, 2020	SELL	$8.89 - $24.94 $36,546 - $102,528	-4,111 Reduced 34.6%	7,769 $83,000
Q4 2019 Feb 05, 2020	SELL	$8.33 - $19.95 $833 - $1,995	-100 Reduced 0.83%	11,880 $222,000
Q3 2019 Nov 08, 2019	BUY	$6.86 - $10.46 $9,309 - $14,194	1,357 Added 12.77%	11,980 $125,000
Q2 2019 Aug 13, 2019	BUY	$6.99 - $11.27 $74,254 - $119,721	10,623 New	10,623 $81,000
Q2 2018 Aug 08, 2018	SELL	$4.04 - $5.13 $49,894 - $63,355	-12,350 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$3.92 - $5.35 $2,598 - $3,547	-663 Reduced 5.09%	12,350 $66,000
Q4 2017 Feb 09, 2018	BUY	$3.9 - $4.66 $237 - $284	61 Added 0.47%	13,013 $51,000
Q3 2017 Nov 09, 2017	BUY	$4.14 - $5.12 $53,621 - $66,314	12,952	12,952 $57,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.